In a House Financial Services Committee hearing on Thursday, Congress appears frustrated in stopping illicit supply chains, and worries about China’s growing resource dominance in high tech and clean tech supply chains.
The trade deficit grew so much in September thanks to Asia imports that the U.S. will import the equivalent of the entire Mexican economy in 2021. A strong dollar is adding to the trade imbalances with Europe, Mexico, China and southeast Asia.
A report by business intel firm Horizon Advisory shows China’s encroachment on the European steel industry. What might it mean for Section 232 tariffs against European steel?
BlackRock is the subject of an ad campaign that will highlight the country’s largest financial institution’s kowtowing to China. Only recently was the company banned from investing in Chinese military contractors. For years, BlackRock has been a funder of China’s military and its surveillance state.
A Boston Celtics player gets the NBA team in trouble in China. But Enes Kanter is showing companies what is truly at stake if they dare go against a CCP narrative.
A senior Chinese official told the U.S. China Business Council that the U.S. and China should partner on EVs and biotech. The private sector can do what it wants. But Washington should not take Beijing up on this offer.
An Indian drug market that’s been the subject of FDA warnings since 2017 is the apparent source of tainted medication sold in the U.S. and Canada. This is another example as to why we need to reshore critical supply of essential medication. Where is Congress?
China’s energy rationing hurts American supply chains already in trouble. Diversification away from China should continue full speed ahead for anyone concerned with economic security.